Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
HELP

Helus Pharma (HELP) stock: insider trades, news & valuation

Health Care · Strong buying
Close · Oct 9, 2026 $11.80 +10.1% on the day +88.2% over 12 months 52-week range $3.87 – $14.02

Share price and insider trades

HELP closeInsider buyInsider sale
051015NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $38,730 on 2026-09-29 · Greg CaversBought $1,043,100 on 2026-08-31 · Paul GlavineBought $1,121,950 on 2026-09-01 · Eric H. L. SoBought $1,178,000 on 2026-09-03 · Paul GlavineBought $1,209,000 on 2026-09-04 · Eric H. L. SoBought $1,347,000 on 2026-09-21 · Michael HalsteadBought $3,733,000 on 2026-09-08 · Eric H. L. So, Paul Glavine
Bought, 12 months$9.7M
Sold, 12 months$0
Insiders buying4
Insiders selling0

Helus Pharma insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $9.7M and 0 sold $0 of HELP stock on the open market, including a cluster buy that began Sep 8, 2026.

HELP insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $9.7M bought (9 trades)$9.7MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$9.7M9—0

Valuation, profit and volume

Pick score 62/100
P/E (trailing)n/aSector median 24.7
Market value$862MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit−$372KOn all tracked purchases -3.9%

Summary

Over the past 12 months, 4 Helus Pharma Inc. insiders reported open-market purchases totaling $9.7M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Sep 8, 2026, when 3 insiders bought a combined $5.1M.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 1SEC Greg CaversCFO Buy 3,000new position $12.91 $39K -8.6% —
Sep 21SEC Michael HalsteadCEO Buy 100,000168,568 held (+146%) $13.47 $1.3M -12.4% —
Sep 11SEC Paul GlavineChief Growth Officer Buy 100,0004,271,252 held (+2%) $12.47 $1.2M -5.4% —
Sep 11SEC Paul GlavineChief Growth Officer Buy 100,0004,271,252 held (+2%) $12.47 $1.2M -5.4% —
Sep 11SEC Eric H. L. SoChair Buy 100,0004,465,014 held (+2%) $12.39 $1.2M -4.8% —
Sep 10SEC Eric H. L. SoChair Buy 100,0004,365,014 held (+2%) $12.09 $1.2M -2.4% —
Sep 10SEC Paul GlavineChief Growth Officer Buy 100,0004,171,252 held (+2%) $11.78 $1.2M +0.2% —
Sep 9SEC Eric H. L. SoChair Buy 95,0004,265,014 held (+2%) $11.81 $1.1M -0.1% —
Sep 9SEC Paul GlavineChief Growth Officer Buy 90,0004,071,252 held (+2%) $11.59 $1.0M +1.8% —

Insiders at Helus Pharma Inc.

InsiderBoughtSoldLast filingScore
Paul GlavineChief Growth Officer $4.7M — Sep 11, 2026 —
Eric H. L. SoChair $3.6M — Sep 11, 2026 —
Michael HalsteadCEO $1.3M — Sep 21, 2026 —
Greg CaversCFO $39K — Oct 1, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

HELP stock: common questions

Are Helus Pharma Inc. insiders buying HELP stock?

In the past 12 months, 4 insiders reported open-market purchases of HELP worth $9.7M. The latest was CFO Greg Cavers bought $39K of HELP at $12.91 — first open-market purchase in our records; opens a new position.

Are Helus Pharma Inc. insiders selling HELP stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is HELP's 52-week range?

Over the past year HELP has traded between $3.87 and $14.02. It last closed at $11.80 on Oct 9, 2026.